Ingredion to Acquire Tate & Lyle for £2.7 Billion at 60% Premium
CP•Ingredion agreed to buy Tate & Lyle for £2.7 billion, offering 595 pence per share plus up to 20 pence in dividends, a 60% premium. Tate & Lyle shares trade below the offer price, reflecting execution and regulatory approval concerns.
1. Deal Terms and Valuation
Ingredion agreed to acquire Tate & Lyle for £2.7 billion ($3.6 billion), offering 595 pence in cash per share plus a potential 20 pence dividend, representing a 60% premium over pre-bid levels.
2. Share Performance Post-Announcement
Following the announcement, Tate & Lyle shares jumped as much as 14% to 560 pence but remain below the offer price, signaling investor concerns over deal completion risk.
3. Regulatory and Execution Risks
Analysts warn that competition authorities, particularly in the US, may scrutinize the combined modified starch operations, while full regulatory approval and integration challenges pose execution risk.
4. Strategic Rationale and Market Impact
The deal marks Tate & Lyle's exit from a near-century of London listing and underscores consolidation in the food ingredients sector as companies vie for healthier product formulations.
